Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

2015/09/30 by Ghodarz Akkasheh, Zahra Kashani-Poor, Maryam Ebrahimi +7 · 7 citations
Biochemistry, Genetics and Molecular Biology · Agricultural and Biological Sciences · Medicine · #Gut microbiota and health #Probiotics and Fermented Foods #Gastrointestinal motility and disorders

paper · doi:10.1016/j.nut.2015.09.003

Citations

• An Inventory for Measuring Depression
• Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
• Assessment of psychotropic-like properties of a probiotic formulation (<i>Lactobacillus helveticus</i>R0052 and<i>Bifidobacterium longum</i>R0175) in rats and human subjects
• The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay

Cited by

• Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
• Role of gut microbiota in depression: Understanding molecular pathways, recent research, and future direction
• Neuroinflammation, Microbiota-Gut-Brain Axis, and Depression: The Vicious Circle
• Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials
• Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder
• Probiotic food consumption is associated with lower severity and prevalence of depression: A nationwide cross-sectional study
• Microbiota-Gut-Brain Axis: New Therapeutic Opportunities